HomeASND • NASDAQ
add
Ascendis Pharma A/S
Previous close
$206.65
Day range
$207.60 - $218.50
Year range
$118.03 - $223.16
Market cap
12.96B USD
Avg Volume
515.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 213.63M | 269.40% |
Operating expense | 180.28M | 25.74% |
Net income | -60.99M | 38.52% |
Net profit margin | -28.55 | 83.35% |
Earnings per share | -1.00 | 41.86% |
EBITDA | 15.02M | 116.26% |
Effective tax rate | -6.30% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 539.09M | -13.82% |
Total assets | 1.15B | 5.57% |
Total liabilities | 1.33B | 11.56% |
Total equity | -174.08M | — |
Shares outstanding | 61.10M | — |
Price to book | -72.51 | — |
Return on assets | 2.45% | — |
Return on capital | 4.42% | — |
Cash Flow
Net change in cash
| (EUR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -60.99M | 38.52% |
Cash from operations | 2.15M | 103.84% |
Cash from investing | -53.00K | 89.46% |
Cash from financing | 38.85M | -90.92% |
Net change in cash | 45.05M | -87.72% |
Free cash flow | 11.40M | 136.23% |
About
Founded
2006
Website
Employees
1,017
